Beraprost

Chemical compound
Pharmaceutical compound
Beraprost
Clinical data
Trade namesDorner
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Pharmacokinetic data
Bioavailability50–70%
MetabolismUnknown
Elimination half-life35–40 minutes
Identifiers
  • 4-{(1R,2R,3aS,8bS)-2-Hydroxy-1-[(1E,3S)-3-hydroxy-4-methyl-1-octen-6-yn-1-yl]-2,3,3a,8b-tetrahydro-1H-benzo[b]cyclopenta[d]furan-5-yl}butanoic acid
CAS Number
  • 88430-50-6 checkY 88475-69-8
PubChem CID
  • 6917951
IUPHAR/BPS
  • 1967
ChemSpider
  • 5293169 checkY
UNII
  • 35E3NJJ4O6
ChEBI
  • CHEBI:135633
ChEMBL
  • ChEMBL1207745 ☒N
CompTox Dashboard (EPA)
  • DTXSID7049136
Chemical and physical data
FormulaC24H30O5
Molar mass398.499 g·mol−1
3D model (JSmol)
  • Interactive image
  • CC#CCC(C)[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C3=CC=CC(=C3O2)CCCC(=O)O)O)O
  • InChI=1S/C24H30O5/c1-3-4-7-15(2)19(25)13-12-17-20(26)14-21-23(17)18-10-5-8-16(24(18)29-21)9-6-11-22(27)28/h5,8,10,12-13,15,17,19-21,23,25-26H,6-7,9,11,14H2,1-2H3,(H,27,28)/b13-12+/t15?,17-,19+,20+,21-,23-/m0/s1 checkY
  • Key:CTPOHARTNNSRSR-APJZLKAGSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Beraprost is a pharmaceutical drug used in several Asian countries, including Japan and South Korea, as a vasodilator and antiplatelet agent.[1] It is classified as a prostacyclin analog.[1][2]

It has been studied for the treatment of pulmonary hypertension and for use in avoiding reperfusion injury.

Clinical pharmacology

As an analog of prostacyclin PGI2, beraprost affects vasodilation, which in turn lowers blood pressure. Beraprost also inhibits platelet aggregation, though the role this phenomenon may play in relation to pulmonary hypertension has yet to be determined.

Dosage and administration

Beraprost is administered orally as a pill available in strength of 20 mcg. Dose ranges from 60 to 180 mcg in divided doses after meals.

References

  1. ^ a b "Beraprost". drugs.com.
  2. ^ Melian EB, Goa KL (2002). "Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension". Drugs. 62 (1): 107–33. doi:10.2165/00003495-200262010-00005. PMID 11790158.


Retrieved from "https://en.wikipedia.org/w/index.php?title=Beraprost&oldid=1330663823"